Theodore Iliopoulos
Chief Operating Officer at Polpharma SA
Theodore Iliopoulos active positions
| Companies | Position | Start | End |
|---|---|---|---|
Polpharma SA
 Polpharma SA Pharmaceuticals: MajorHealth Technology Polpharma SA develops and manufactures generic drugs. It offers food for special medical purposes, on prescription, no prescription, and medical products. The company was founded in 1935 and is headquartered in Starogard Gdanski, Poland. | Chief Operating Officer | 2001-12-31 | - |
Career history of Theodore Iliopoulos
Former positions of Theodore Iliopoulos
| Companies | Position | Start | End |
|---|---|---|---|
| PATHEON, INC. | Chief Operating Officer | - | - |
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | - | - |
Training of Theodore Iliopoulos
| National & Kapodistrian University of Athens | Undergraduate Degree |
Statistics
International
| Poland | 2 |
| Greece | 2 |
| United States | 2 |
Operational
| Chief Operating Officer | 2 |
| Undergraduate Degree | 1 |
| Corporate Officer/Principal | 1 |
Sectoral
| Health Technology | 4 |
| Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
| Private companies | 2 |
|---|---|
Polpharma SA
Polpharma SA Pharmaceuticals: MajorHealth Technology Polpharma SA develops and manufactures generic drugs. It offers food for special medical purposes, on prescription, no prescription, and medical products. The company was founded in 1935 and is headquartered in Starogard Gdanski, Poland. | Health Technology |
Patheon, Inc.
 Patheon, Inc. Pharmaceuticals: MajorHealth Technology Patheon, Inc. provides drug development and manufacturing services to global pharmaceutical, biotechnology and specialty pharmaceutical companies. It operates through two segments: Commercial Manufacturing Outsourcing and Pharmaceutical Development Services. The Commercial Manufacturing Outsourcing segment manufactures prescription products in sterile dosage forms as well as solid and liquid conventional dosage forms. The Pharmaceutical Development Services segment provides a broad range of development services, including solid and sterile dosage forms. The company operates through four market segments: Biologics, Emerging Pharma, Generics and Large Pharma. Patheon was founded in 1974 and is headquartered in Mississauga, Canada. | Health Technology |
- Stock Market
- Insiders
- Theodore Iliopoulos
- Experience
